Shift Biosciences, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the appointments of Jill Reckless, Ph.D, as Translation Advisor and Laurence Reid, Ph.D., as Non-Executive Director. In these roles, Jill and Laurence will guide Shift in building a robust product translation and business development strategy respectively, enabling the Company to capitalize on early momentum and progress its pipeline of novel rejuvenation therapeutics towards clinical development.
Exactech files for Chapter 11, agrees to investor buyout
Dive Brief: Exactech has filed for Chapter 11 bankruptcy protection and agreed to sell its assets to existing investors, the company said Tuesday. The bankruptcy